Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients

• Status: Completed
• Trial end date: 2015-06-01
• Target enrollment: 0
• Participant gender: All

Summary

entGlycemic control has been found to improve clinical outcomes following Coronary Bypass Surgery. This study tests the hypothesis that obtaining tighter glycemic control(80-120mg/dl) as opposed to more moderate control (120-180mg/dl) will further improve outcomes.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: American Heart Association
• Collaborator: Eli Lilly and Company
• Treatments: Insulin; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• All diabetic patients undergoing Coronary Bypass Surgery

Exclusion Criteria:

• Patients with hepatic and renal failure